102 related articles for article (PubMed ID: 15433253)
21. Clinical, humoral, and pathologic findings in adult alpacas with experimentally induced Corynebacterium pseudotuberculosis infection.
Braga WU; Chavera AE; González AE
Am J Vet Res; 2006 Sep; 67(9):1570-4. PubMed ID: 16948603
[TBL] [Abstract][Full Text] [Related]
22. Pilot immunization of mice infected with an equine strain of Corynebacterium pseudotuberculosis.
Gorman JK; Gabriel M; MacLachlan NJ; Nieto N; Foley J; Spier S
Vet Ther; 2010; 11(1):E1-8. PubMed ID: 20949428
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in susceptibility of ICR mice to oral infection with Corynebacterium kutscheri.
Komukai Y; Amao H; Goto N; Kusajima Y; Sawada T; Saito M; Takahashi KW
Exp Anim; 1999 Jan; 48(1):37-42. PubMed ID: 10067204
[TBL] [Abstract][Full Text] [Related]
24. Serological studies of Corynebacterium kutscheri and coryneform bacteria using an enzyme-linked immunosorbent assay (ELISA).
Boot R; Thuis H; Bakker R; Veenema JL
Lab Anim; 1995 Jul; 29(3):294-9. PubMed ID: 7564214
[TBL] [Abstract][Full Text] [Related]
25. [Survival capacity of Corynebacterium pseudotuberculosis biovar ovis in different soil types from Chubut, Argentine Patagonia].
Alvarez L; William A; Castro I; Valenzuela F; Estevao Belchior S
Rev Argent Microbiol; 2017; 49(1):105-109. PubMed ID: 28063624
[TBL] [Abstract][Full Text] [Related]
26. Complement receptor type 3 plays an important role in development of protective immunity to primary and secondary Corynebacterium pseudotuberculosis infection in mice.
Lan DT; Makino S; Shirahata T; Yamada M; Nakane A
Microbiol Immunol; 1999; 43(12):1103-6. PubMed ID: 10656178
[TBL] [Abstract][Full Text] [Related]
27. Musculoskeletal Corynebacterium pseudotuberculosis infection in horses: 35 cases (1999-2009).
Nogradi N; Spier SJ; Toth B; Vaughan B
J Am Vet Med Assoc; 2012 Sep; 241(6):771-7. PubMed ID: 22947161
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Proteomic Analysis Reveals Changes in the Benchmark
Silva WM; Carvalho RDO; Dorella FA; Folador EL; Souza GHMF; Pimenta AMC; Figueiredo HCP; Le Loir Y; Silva A; Azevedo V
Front Cell Infect Microbiol; 2017; 7():325. PubMed ID: 28791255
[No Abstract] [Full Text] [Related]
29. Chronic equine absesses associated with Corynebacterium pseudotuberculosis.
HUGHES JP; BIBERSTEIN EL
J Am Vet Med Assoc; 1959 Dec; 135():559-62. PubMed ID: 14403867
[No Abstract] [Full Text] [Related]
30. Lack of interference with diagnostic testing for tuberculosis in goats experimentally exposed to Corynebacterium pseudotuberculosis.
Bezos J; Casal C; Romero B; Liandris E; Sánchez N; Vigo V; Domínguez L; de Juan L
Vet J; 2015 Jul; 205(1):113-5. PubMed ID: 25975852
[TBL] [Abstract][Full Text] [Related]
31. Minimum inhibitory concentrations of equine Corynebacterium pseudotuberculosis isolates (1996-2012).
Rhodes DM; Magdesian KG; Byrne BA; Kass PH; Edman J; Spier SJ
J Vet Intern Med; 2015 Jan; 29(1):327-32. PubMed ID: 25586790
[TBL] [Abstract][Full Text] [Related]
32. Survival of Corynebacterium pseudotuberculosis within macrophages and induction of phagocytes death.
Stefańska I; Gieryńska M; Rzewuska M; Binek M
Pol J Vet Sci; 2010; 13(1):143-9. PubMed ID: 21077443
[TBL] [Abstract][Full Text] [Related]
33. Frequency of Corynebacterium pseudotuberculosis infection in horses across the United States during a 10-year period.
Kilcoyne I; Spier SJ; Carter CN; Smith JL; Swinford AK; Cohen ND
J Am Vet Med Assoc; 2014 Aug; 245(3):309-14. PubMed ID: 25029310
[TBL] [Abstract][Full Text] [Related]
34. The effect of selected viruses on Corynebacterium kutscheri infection in rats.
Barthold SW; Brownstein DG
Lab Anim Sci; 1988 Oct; 38(5):580-3. PubMed ID: 2848153
[TBL] [Abstract][Full Text] [Related]
35. Corynebacterium kutscheri and its alleged avirulent variant in mice.
Hirst RG; Olds RJ
J Hyg (Lond); 1978 Jun; 80(3):349-56. PubMed ID: 649947
[TBL] [Abstract][Full Text] [Related]
36. Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production.
Soares SC; Trost E; Ramos RT; Carneiro AR; Santos AR; Pinto AC; Barbosa E; Aburjaile F; Ali A; Diniz CA; Hassan SS; Fiaux K; Guimarães LC; Bakhtiar SM; Pereira U; Almeida SS; Abreu VA; Rocha FS; Dorella FA; Miyoshi A; Silva A; Azevedo V; Tauch A
J Biotechnol; 2013 Aug; 167(2):135-41. PubMed ID: 23201561
[TBL] [Abstract][Full Text] [Related]
37. Local action of some antibacterial substances against Corynebacterium ovis in guinea-pig skin.
COLLIER HO; GRIMSHAW JJ
Br J Pharmacol Chemother; 1958 Sep; 13(3):231-7. PubMed ID: 13584722
[TBL] [Abstract][Full Text] [Related]
38. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
Droppa-Almeida D; Vivas WL; Silva KK; Rezende AF; Simionatto S; Meyer R; Lima-Verde IB; Delagostin O; Borsuk S; Padilha FF
Vaccine; 2016 Feb; 34(8):1091-6. PubMed ID: 26796140
[TBL] [Abstract][Full Text] [Related]
39. [Axillary lymphadenitis due to Corynebacterium pseudotuberculosis in a 63-year-old patient].
Hémond V; Rosenstingl S; Auriault ML; Galanti MJ; Gatfosse M
Med Mal Infect; 2009 Feb; 39(2):136-9. PubMed ID: 19013041
[TBL] [Abstract][Full Text] [Related]
40. [Screening of Corynebacterium diphtheriae, Corynebacterium ulcerans and Corynebacterium pseudotuberculosis in throat swab specimens of children with upper respiratory tract infections].
Gayretli Aydın ZG; Tanır G; Nar Ötgün S; Turan M; Aydın Teke T; Kaman A; Kılıç S
Mikrobiyol Bul; 2017 Jul; 51(3):209-219. PubMed ID: 28929958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
